Nasser S. Al‐Shakliah

Development of novel synthesized phthalazinone-based PARP-1 inhibitors with apoptosis inducing mechanism in lung cancer

Hadia Almahli, Élie Hadchity, Maiy Y. Jaballah et al. · Bioorganic Chemistry · 2018 · 74 citations

Medicine, Medicinal Chemistry, Oncology +12

Facile synthesis and characterization of ZnO nanoparticles for studying their biological activities and photocatalytic degradation properties toward methylene blue dye

Abdulrahman A. Almehizia, Mohamed A. Al‐Omar, Ahmed M. Naglah et al. · Alexandria Engineering Journal · 2021 · 66 citations · Full text

Natural Sciences, Materials Engineering, Materials Science +16

Identification and characterization of in vivo, in vitro and reactive metabolites of vandetanib using LC–ESI–MS/MS

Mohamed W. Attwa, Adnan A. Kadi, Hany W. Darwish et al. · Chemistry Central Journal · 2018 · 41 citations · Full text

Medicine, Pharmacology, Toxicology +16

A highly efficient and sensitive LC‐MS/MS method for the determination of afatinib in human plasma: application to a metabolic stability study

Adnan A. Kadi, Ali S. Abdelhameed, Hany W. Darwish et al. · Biomedical Chromatography · 2015 · 34 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +14

Identification and characterization of <i>in silico</i>, <i>in vivo</i>, <i>in vitro</i>, and reactive metabolites of infigratinib using LC-ITMS: bioactivation pathway elucidation and <i>in silico</i> toxicity studies of its metabolites

Nasser S. Al‐Shakliah, Mohamed W. Attwa, Adnan A. Kadi et al. · RSC Advances · 2020 · 34 citations · Full text

Medicine, Oncology, Pharmacology +16